The Prognostic Impact of Myelodysplasia-Related Gene Mutations in Acute Myeloid Leukemia with FLT3-ITD Mutations

被引：0

作者：

Mecklenbrauck, Rabea ^{[1
,2
]}

Ramiro, Angela Villaverde ^{[3
]}

Straeng, Eric ^{[4
]}

Gabdoulline, Razif ^{[1
]}

Elicegui, Javier Martinez ^{[3
]}

Sobas, Marta ^{[5
]}

Pleyer, Lisa ^{[6
]}

Voso, Maria Teresa ^{[7
]}

Benner, Axel ^{[8
]}

Sanchez, Alberto Hernandez ^{[9
]}

Tettero, Jesse M. ^{[10
]}

Tur, Laura ^{[11
]}

Metzeler, Klaus H. ^{[12
]}

Onate, Guadalupe ^{[13
]}

Lehmann, Soren ^{[14
]}

Huntly, Brian J. P. ^{[15
,16
]}

Thomas, Ian ^{[17
]}

Thol, Felicitas R. ^{[1
]}

Heidel, Florian ^{[1
]}

Valk, Peter J. M. ^{[18
]}

Doehner, Konstanze ^{[19
]}

Haferlach, Torsten ^{[20
]}

Mills, Ken, I ^{[21
]}

Doehner, Hartmut ^{[19
]}

Castellani, Gastone ^{[22
]}

Ossenkoppele, Gert

Rivas, Jesus Maria Hernandez ^{[9
]}

Bullinger, Lars ^{[4
]}

Heuser, Michael ^{[1
,23
]}

机构：

[1] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpla, Hannover, Germany

[2] Univ Oxford, Weatherall Inst Med, Radcliffe Dept Med, MRC Mol Haematol Unit, Oxford, England

[3] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain

[4] Charite, Dept Hematol Oncol Tumor Immunol, Berlin, Germany

[5] Med Univ Wroclaw, Dept Hematol Blood Neoplasms & Bone Marrow Transpl, Wroclaw, Poland

[6] Paracelsus Med Univ, Oncol Ctr, Med Dept Haematol Med Oncol Haemostaseol Rheumatol, Salzburg, Austria

[7] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy

[8] German Canc Res Ctr, Div Biostat, Heidelberg, Germany

[9] Hosp Univ Salamanca CAUSA IBSAL, Hematol Dept, Salamanca, Spain

[10] Amsterdam UMC Locat Vrije Univ Amsterdam, Dept Hematol, Amsterdam, Netherlands

[11] GMV Innovating Solut, Valencia, Spain

[12] Univ Leipzig, Dept Hematol Cellular Therapy, Med Ctr, Leipzig, Germany

[13] Hosp Santa Creu & Sant Pau, Dept Paediat, Barcelona, Spain

[14] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med Huddinge, Stockholm, Sweden

[15] Univ Cambridge, Dept Haematol, Cambridge, England

[16] Univ Cambridge, Cambridge Stem Cell Inst, Cambridge, England

[17] Cardiff Univ, Ctr Trials Res, Cardiff, Wales

[18] Erasmus Univ, Med Ctr, Rotterdam, Netherlands

[19] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

[20] MLL Munich Leukemia Lab, Munich, Germany

[21] Queens Univ Belfast, Patrick G Johnston Ctr Canc Res, Belfast, North Ireland

[22] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy

[23] Univ Hosp Halle Saale, Dept Internal Med 4, Halle An Der Saale, Saale, Germany

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-202362

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

615

引用

页码：844 / 846

页数：3

共 50 条

[21] Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations
Shoukier, Mahran
Kadia, Tapan
Konopleva, Marina
Alotaibi, Ahmad S.
Alfayez, Mansour
Loghavi, Sanam
Patel, Keyur P.
Kanagal-Shamanna, Rashmi
Cortes, Jorge
Samra, Bachar
Jabbour, Elias
Garcia-Manero, Guillermo
Takahashi, Koichi
Pierce, Sherry
Short, Nicholas J.
Yilmaz, Musa
Sasaki, Koji
Masarova, Lucia
Pemmaraju, Naveen
Borthakur, Gautam
Kantarjian, Hagop M.
Ravandi, Farhad
DiNardo, Courtney D.
Daver, Naval
CANCER, 2021, 127 (03) : 381 - 390
[22] Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia
De Bellis, Eleonora
Ottone, Tiziana
Mercante, Lisa
Falconi, Giulia
Cugini, Elisa
Consalvo, Maria Irno
Travaglini, Serena
Paterno, Giovangiacinto
Piciocchi, Alfonso
Rossi, Elisa Linnea Lindfors
Gurnari, Carmelo
Maurillo, Luca
Buccisano, Francesco
Arcese, William
Voso, Maria Teresa
LEUKEMIA RESEARCH, 2020, 99
[23] A COMPARATIVE STUDY OF VARIOUS FLT3-ITD MUTATIONS ISOLATED FROM ACUTE MYELOID LEUKEMIA PATIENTS
Nordigarden, Amanda
Halvarsson, Camilla
Tang, Yanjuan
Druid, Pia
Jonsson, Jan-Ingvar
EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S130 - S131
[24] Treatment of FLT3-ITD acute myeloid leukemia
Fathi, Amir T.
Chen, Yi-Bin
AMERICAN JOURNAL OF BLOOD RESEARCH, 2011, 1 (02): : 175 - 189
[25] The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics
How, J.
Sykes, J.
Minden, M. D.
Gupta, V.
Yee, K. W. L.
Schimmer, A. D.
Schuh, A. C.
Kamel-Reid, S.
Brandwein, J. M.
BLOOD CANCER JOURNAL, 2013, 3 : e116 - e116
[26] FLT3-ITD As a Prognostic Factor for Chinese Patients with Acute Myeloid Leukemia
Sun, Jie
He, Jingsong
Wei, Guoqing
Zheng, Weiyan
Shi, Jimin
Luo, Yi
Huang, He
BLOOD, 2016, 128 (22)
[27] Prognostic Value of FLT3-ITD Residual Disease in Acute Myeloid Leukemia
Vonk, Christian
Grob, Tim
Sanders, Mathijs
Kavelaars, Francois
Rijken, Melissa
Hanekamp, Diana
Gradowska, Patrycja
Cloos, Jaqueline
Floisand, Yngvar
Kooy, Marinus Van Marwijk
Manz, Markus
Ossenkoppele, Gert
Tick, Lidwine
Vekemans, Marie-Christiane
Lowenberg, Bob
Jongen-Lavrencic, Mojca
Valk, Peter
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S227 - S227
[28] FLT3 AND NPM1 GENE MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIAS AND THE IMPACT OF FLT3-ITD MUTATIONS ON THE SURVIVAL OF PATIENTS WITH A NORMAL KARYOTYPE
Martynkevich, I. S.
Gritsayev, S. V.
Moskalenko, M. V.
Ivanova, M. P.
Aksenova, V. Yu
Tiranova, S. A.
Abdulkadyrov, K. M.
TERAPEVTICHESKII ARKHIV, 2010, 82 (12) : 33 - 39
[29] Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
Choi, Sujin
Kim, Bo Kyung
Ahn, Hong Yul
Hong, Kyung Taek
Choi, Jung Yoon
Shin, Hee Young
Kang, Hyoung Jin
BLOOD RESEARCH, 2020, 55 (04) : 217 - 224
[30] TET2, ANPM1 and FLT3-ITD Gene Mutations in Normal Karyotype Acute Myeloid Leukemia
Sun, Aining
Tian, Xiaopeng
Yin, Jia
Li, Weiyang
Chen, Suning
Wu Depei
BLOOD, 2012, 120 (21)

← 1 2 3 4 5 →